Skip to main content

Vitamin D levels among HIV-infected patients – peculiar features

Background

25-hydroxyvitamin D (25[OH]D) plays an essential role in the homeostasis of calcium and bone metabolism, but it is acknowledged as an immunomodulator as well. Several studies have described a high prevalence of 25[OH]D deficiency in HIV-infected patients, as well as its role in predicting disease progression.

Methods

We performed a descriptive, cross-sectional study on a group of 68 HIV-infected patients monitored in the Regional HIV/AIDS Centre Mureş, during December 2012-February 2013. We determined plasma levels of 25[OH]D. We estimated the proportion of patients with 25[OH]D deficiency/insufficiency and correlated 25[OH]D levels to HIV-RNA plasma viral load, CD4+ T-cells count and associated pathology. Data were compared to those obtained from a group of healthy, HIV-negative volunteers. Statistical analysis was performed using the GraphPad program.

Results

We studied 68 C-stage HIV-infected patients, 40 male: 28 female, with an average age of 26 and a median of 23. The average plasma 25[OH]D level was 30.94 ng/mL, median 30 ng/mL in HIV-positive patients compared to an average of 44.72 ng/mL and median 39.82 ng/mL in HIV-negative subjects (p=0.0109). 25[OH]D deficiency <20 ng/mL was found in 23.52% HIV-infected patients, while 26.47% HIV-positive subjects had medium levels of 25[OH]D insufficiency, between 20-30 ng/mL. Only 2 patients had severe 25[OH]D deficiency, below 10 ng/mL. We did not find any statistically significant correlations of 25[OH]D levels with CD4+ T-cells level, HIV-RNA plasma viral load or protease inhibitor therapy. Patients with HIV-tuberculosis co-infection had significantly lower levels of 25[OH]D (p=0.0454) than HIV-positive subjects without tuberculosis.

Conclusion

25[OH]D plasma levels are lower in HIV-infected patients compared to the general population. Low 25[OH]D levels are reported in patients with HIV-tuberculosis co-infection. Low 25[OH]D levels may indicate unfavorable outcome in HIV-infected patients.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Carmen Chiriac.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Chiriac, C., Zaharia-Kezdi, I.E., Ţilea, B. et al. Vitamin D levels among HIV-infected patients – peculiar features. BMC Infect Dis 13, P11 (2013). https://doi.org/10.1186/1471-2334-13-S1-P11

Download citation

Keywords

  • Tuberculosis
  • Plasma Level
  • Bone Metabolism
  • Inhibitor Therapy
  • Unfavorable Outcome